Payment overview · 2025
General Payments
$108.05
6 reported records · 4 companies
Healthcare provider profile · identity verified
George Mitchell Cornett, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FRANKLIN, IN · NPI 1902808199
Verified facts
What the public records show
CMS Open Payments records show George Mitchell Cornett, M.D. received $108.05 in general payments during 2025 across 6 reported records.
Abbott Laboratories accounted for 37.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $40.44 | 37.4% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $36.98 | 34.2% | 2 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.40 | 14.2% | 1 | 2025 |
| Organon LLC | Unresolved — no canonical attribution shown | $15.23 | 14.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $108.05 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $40.44 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $36.98 | 2 | 2025 |
Source payment records
|
|||||
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $15.40 | 1 | 2025 |
Source payment records
|
|||||
| NEXPLANON Normalized: nexplanon |
Drug | Organon LLC | $15.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 689 | 195 |
| Levothyroxine Sodium | Levothyroxine Sodium | 487 | 120 |
| Metoprolol Succinate | Metoprolol Succinate | 400 | 94 |
| Lisinopril | Lisinopril | 387 | 113 |
| Omeprazole | Omeprazole | 319 | 83 |
| Amlodipine Besylate | Amlodipine Besylate | 276 | 76 |
| Gabapentin | Gabapentin | 255 | 57 |
| Metformin Hcl | Metformin Hcl | 238 | 66 |
| Potassium Chloride | Potassium Chloride | 238 | 58 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 236 | 52 |
| Pravastatin Sodium | Pravastatin Sodium | 235 | 47 |
| Sertraline Hcl | Sertraline Hcl | 213 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 208 | 57 |
| Furosemide | Furosemide | 200 | 59 |
| Alprazolam | Alprazolam | 197 | 25 |
| Losartan Potassium | Losartan Potassium | 192 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 184 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 166 | 46 |
| Jardiance | Empagliflozin | 166 | 37 |
| Mounjaro | Tirzepatide | 144 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 142 | 43 |
| Diclofenac Sodium | Diclofenac Sodium | 141 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 140 | 37 |
| Alendronate Sodium | Alendronate Sodium | 138 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 133 | 39 |
| Tramadol Hcl | Tramadol Hcl | 127 | 33 |
| Eliquis | Apixaban | 123 | 27 |
| Ezetimibe | Ezetimibe | 121 | 34 |
| Glimepiride | Glimepiride | 117 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 25 |
| Carvedilol | Carvedilol | 109 | 34 |
| Buspirone Hcl | Buspirone Hcl | 107 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 106 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 24 |
| Allopurinol | Allopurinol | 103 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 96 | 22 |
| Finasteride | Finasteride | 93 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 89 | 24 |
| Ozempic | Semaglutide | 83 | 17 |
| Raloxifene Hcl | Raloxifene Hcl | 81 | 19 |
| Cephalexin | Cephalexin | 76 | 47 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 74 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 23 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 70 | 57 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 69 | 17 |
| Trulicity | Dulaglutide | 69 | 17 |
| Benazepril Hcl | Benazepril Hcl | 68 | 15 |
| Januvia | Sitagliptin Phosphate | 68 | 20 |
| Trazodone Hcl | Trazodone Hcl | 68 | 26 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 67 | 59 |
| Torsemide | Torsemide | 65 | 18 |
| Spironolactone | Spironolactone | 63 | 22 |
| Montelukast Sodium | Montelukast Sodium | 62 | 13 |
| Memantine Hcl | Memantine Hcl | 61 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 61 | 23 |
| Lorazepam | Lorazepam | 60 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 59 | 19 |
| Bupropion Hcl Sr | Bupropion Hcl | 57 | 12 |
| Meloxicam | Meloxicam | 56 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 56 | 12 |
| Pregabalin | Pregabalin | 56 | 18 |
| Simvastatin | Simvastatin | 55 | 17 |
| Propranolol Hcl | Propranolol Hcl | 53 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 52 | 42 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 47 | 13 |
| Atenolol | Atenolol | 45 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 45 | 17 |
| Famotidine | Famotidine | 45 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 45 | suppressed |
| Valsartan | Valsartan | 45 | 13 |
| Clonazepam | Clonazepam | 43 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 40 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 11 |
| Metformin Hcl Er | Metformin Hcl | 39 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 22 |
| Pioglitazone Hcl | Pioglitazone Hcl | 37 | suppressed |
| Nifedipine Er | Nifedipine | 35 | suppressed |
| Prednisone | Prednisone | 35 | 24 |
| Xarelto | Rivaroxaban | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | 13 |
| Colchicine | Colchicine | 34 | 18 |
| Estradiol | Estradiol | 34 | 12 |
| Donepezil Hcl | Donepezil Hcl | 33 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Mirtazapine | Mirtazapine | 33 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 32 | 32 |
| Diazepam | Diazepam | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Celecoxib | Celecoxib | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 21 |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 11 |
| Morphine Sulfate | Morphine Sulfate | 27 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 23 |
| Divalproex Sodium | Divalproex Sodium | 26 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | 11 |
| Levetiracetam | Levetiracetam | 25 | suppressed |
| Loperamide | Loperamide Hcl | 25 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 25 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Nystatin | Nystatin | 24 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Rybelsus | Semaglutide | 24 | suppressed |
| Amoxicillin | Amoxicillin | 23 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Fluconazole | Fluconazole | 23 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 16 |
| Eszopiclone | Eszopiclone | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 19 | suppressed |
| Trimethoprim | Trimethoprim | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 18 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Methadone Hcl | Methadone Hcl | 18 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 18 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 18 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Premarin | Estrogens, Conjugated | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | 11 |
| Nitroglycerin | Nitroglycerin | 16 | 12 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 16 | suppressed |
| Azithromycin | Azithromycin | 15 | 14 |
| Cefdinir | Cefdinir | 15 | 11 |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Klayesta | Nystatin | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $108.05 · 6 records | Abbott Laboratories | FREESTYLE LIBRE 3, NEXPLANON, The Cologuard Plus Collection Kit, VENASEAL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error